Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jann-Yuan Wang

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Chest|October 2, 2013
ResponseJung-Yien Chien, Jann-Yuan Wang
The Lancet. Infectious Diseases|March 1, 2017
Isoniazid-resistant tuberculosis treatment with first-line drugsJung-Yien Chien, Jann-Yuan Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Active tuberculosis during temsirolimus and bevacizumab treatmentChia-Chi Lin, Jann-Yuan Wang, Yeong-Shiau Pu
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 1, 2022
Association of pulmonary nontuberculous mycobacteria with the outcomes of patients with lung cancer: A retrospective matched cohort study with a special emphasis on the impact of chemotherapyTing-Yu Liao, Jann-Yuan Wang, Jin-Yuan Shih
Respirology (Carlton, Vic.)|November 17, 2010
Increased prevalence of primary drug-resistant pulmonary tuberculosis in immunocompromised patientsJung-Rern Jiang, Shiao-Yu Yen, Jann-Yuan Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Gefitinib or Erlotinib for Previously Treated Lung Adenocarcinoma: Which Is Superior?Chia-Hao Chang, Chih-Hsin Lee, Jann-Yuan Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2013
Reply to S. ValeChia-Chi Lin, Jann-Yuan Wang, Yeong-Shiau Pu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 1, 2020
Time to be familiar with nontuberculous mycobacterial lung disease - An emerging disease with diverse clinical outcomesJann-Yuan Wang, Jin-Yuan Shih, Meng-Chih Lin
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 16, 2019
Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: Retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002-2013Argita D Salindri, Jann-Yuan Wang, Hsien-Ho Lin, et al.
European Journal of Haematology|December 17, 2008
Cooley's anemiaChin-Chi Kuo, Jann-Yuan Wang, Ching-Wei Tsai, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Chest|October 2, 2013
ResponseJung-Yien Chien, Jann-Yuan Wang
The Lancet. Infectious Diseases|March 1, 2017
Isoniazid-resistant tuberculosis treatment with first-line drugsJung-Yien Chien, Jann-Yuan Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Active tuberculosis during temsirolimus and bevacizumab treatmentChia-Chi Lin, Jann-Yuan Wang, Yeong-Shiau Pu
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 1, 2022
Association of pulmonary nontuberculous mycobacteria with the outcomes of patients with lung cancer: A retrospective matched cohort study with a special emphasis on the impact of chemotherapyTing-Yu Liao, Jann-Yuan Wang, Jin-Yuan Shih
Respirology (Carlton, Vic.)|November 17, 2010
Increased prevalence of primary drug-resistant pulmonary tuberculosis in immunocompromised patientsJung-Rern Jiang, Shiao-Yu Yen, Jann-Yuan Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2017
Gefitinib or Erlotinib for Previously Treated Lung Adenocarcinoma: Which Is Superior?Chia-Hao Chang, Chih-Hsin Lee, Jann-Yuan Wang
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2013
Reply to S. ValeChia-Chi Lin, Jann-Yuan Wang, Yeong-Shiau Pu
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 1, 2020
Time to be familiar with nontuberculous mycobacterial lung disease - An emerging disease with diverse clinical outcomesJann-Yuan Wang, Jin-Yuan Shih, Meng-Chih Lin
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 16, 2019
Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: Retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002-2013Argita D Salindri, Jann-Yuan Wang, Hsien-Ho Lin, et al.
European Journal of Haematology|December 17, 2008
Cooley's anemiaChin-Chi Kuo, Jann-Yuan Wang, Ching-Wei Tsai, et al.
Pageof 22